D. Ducloux

发表

Mycophenolate Mofetil-Induced Dyshidrotic Eczema

J. Miguet, S. Semhoun-Ducloux, D. Ducloux, 2000, Annals of Internal Medicine.

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score

A. Kazory, C. Courivaud, D. Ducloux, 2019, BMC Nephrology.

Influence of Fractalkine Receptor Gene Polymorphisms V249I-T280M on Cancer Occurrence After Renal Transplantation

M. Deschamps, P. Tiberghien, C. Borg, 2013, Transplantation.

Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients

P. Tiberghien, C. Borg, P. Saas, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Pretransplant Serum Vitamin D Levels and Risk of Cancer After Renal Transplantation

A. Kazory, C. Courivaud, G. Dumoulin, 2008, Transplantation.

Peritoneal dialysis after kidney transplant failure: a nationwide matched cohort study from the French Language Peritoneal Dialysis Registry (RDPLF).

D. Vernerey, T. Lobbedez, C. Courivaud, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

CD 4 Cell Lymphopenia and Atherosclerosis in Renal Transplant Recipients

P. Tiberghien, P. Saas, B. Challier, 2003 .

CD4 cell lymphopenia and atherosclerosis in renal transplant recipients.

P. Tiberghien, P. Saas, B. Challier, 2003, Journal of the American Society of Nephrology : JASN.

Mycophenolate mofetil-induced villous atrophy.

J. Miguet, P. Carayon, S. Semhoun-Ducloux, 1998, Transplantation.

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

G. Choukroun, C. Legendre, D. Vernerey, 2019, Trials.

The first case of JC virus allograft nephropathy.

A. Kazory, R. Angonin, B. Fontanière, 2003, Transplantation.

Peritoneal Dialysis Reduces the Number of Hospitalization Days in Heart Failure Patients Refractory to Diuretics

A. Kazory, R. Azar, C. Courivaud, 2014, Peritoneal Dialysis International.

Effect of adding vildagliptin to insulin in haemodialysed patients with type 2 diabetes: The VILDDIAL study, a randomized, multicentre, prospective study

T. Hannedouche, B. Guerci, L. Meyer, 2020, Diabetes, obesity & metabolism.

Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study.

A. Kazory, C. Courivaud, D. Ducloux, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1997, Transplantation.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1998 .

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients

M. Deschamps, P. Tiberghien, P. Saas, 2011, Journal of Transplantation.

Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series

E. Thervet, P. Bruneval, J. Goujon, 2022, American Journal of Kidney Diseases.

CD4 T Lymphopenia, Thymic Function, Homeostatic Proliferation and Late Complications Associated with Kidney Transplantation

P. Saas, B. Gaugler, C. Courivaud, 2013 .

Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.

R. Gibey, B. Challier, D. Ducloux, 2000, Journal of the American Society of Nephrology : JASN.

Living kidney donor evaluation for all candidates with normal estimated GFR for age

P. Rieu, L. Rostaing, N. Kamar, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Temporal trends in living kidney donation in France between 2007 and 2017.

P. Rieu, L. Rostaing, N. Kamar, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

No evidence of association between NOD 2 / CARD 15 gene polymorphism and atherosclerotic events after renal transplantation

M. Deschamps, C. Ferrand, A. Duperrier, 2017 .

Alloimmune Responses and Atherosclerotic Disease After Kidney Transplantation

P. Saas, B. Gaugler, C. Courivaud, 2015, Transplantation.

No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2006, Transplantation.

Pretransplant coronary artery disease screening is still valid.

C. Courivaud, D. Ducloux, J. Rebibou, 2021, Kidney international.

Impact of malnutrition-inflammation on the association between homocysteine and mortality.

A. Kazory, D. Ducloux, N. Devillard, 2006, Kidney international.

Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients.

C. Ferrand, P. Saas, C. Courivaud, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial

O. Toupance, C. Pouteil‐Noble, P. Lang, 2016, Transplantation.

Clinical features and outcome of infection-related glomerulonephritis with IgA deposits

Emilie Cornec-Le Gall, L. Doucet, J. Goujon, 2020 .

Impact of polyclonal antithymocyte globulins on kidney transplant outcomes in real-life: a propensity score analysis

P. Rieu, A. Heng, L. Frimat, 2019 .

Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2014, Journal of the American Society of Nephrology : JASN.

Long‐term follow‐up of renal transplant recipients treated with losartan for post‐transplant erythrosis

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998 .

Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients

D. Ducloux, G. Motte, J. Chalopin, 2001, Journal of Human Hypertension.

Serum immunoglobulin G levels and peritonitis in peritoneal dialysis patients

K. Bardonnet, C. Courivaud, D. Ducloux, 2015, Journal of Nephrology.

Acquired hypercoagulable state in renal transplant recipients

A. Kazory, D. Ducloux, 2004, Thrombosis and Haemostasis.

Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysis patients.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients.

P. Tiberghien, P. Saas, C. Courivaud, 2013, The Journal of infectious diseases.

Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.

G. Toubin, Z. Massy, T. Drüeke, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Subclinical Epstein–Barr Virus Viremia Among Adult Renal Transplant Recipients: Incidence and Consequences

P. Saas, A. Coaquette, C. Courivaud, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts: serial baroreflex responses

J. Fortrat, J. Regnard, M. Bouhaddi, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Six‐month cardiovascular changes in cyclosporine‐treated recipients of corneal grafts: serial baroreflex responses

J. Fortrat, J. Regnard, M. Bouhaddi, 2004 .

Homocysteine, nutritional status and insulin in renal transplant recipients.

R. Gibey, D. Ducloux, J. Chalopin, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase.

J. Pais de Barros, P. Gambert, L. Lagrost, 2007, Kidney international.

Homocysteine in cerebral macroangiopathy and microangiopathy

D. Ducloux, Jean-Marc Chapolin, 1999, The Lancet.

Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients.

D. Ducloux, J. Chalopin, G. Motte, 2003, Kidney international.

Significant increase in 1-year posttransplant renal arterial index predicts graft loss.

B. Kastler, C. Courivaud, D. Ducloux, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study

P. Tiberghien, D. Vernerey, P. Saas, 2022, Frontiers in Immunology.

Immune phenotype predicts new onset diabetes after kidney transplantation.

P. Saas, C. Courivaud, S. Borot, 2019, Human immunology.

Antithymocytes globulins: Time to revisit its use in kidney transplantation?

P. Saas, C. Courivaud, D. Ducloux, 2018, International reviews of immunology.

Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric‐coated mycophenolate sodium and steroids: results of follow up to 30 months post‐transplant

L. Rostaing, N. Kamar, C. Pouteil‐Noble, 2007, Clinical transplantation.

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications

P. Saas, C. Courivaud, D. Ducloux, 2018, Immunity & ageing : I & A.

Effect of losartan on haemoglobin concentration in renal transplant recipients--a retrospective analysis.

D. Ducloux, J. Chalopin, Y. Saint-Hillier, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Postrenal transplant erythrosis: a direct role for angiotensin II.

D. Ducloux, J. Chalopin, V. Fournier, 1997, Clinical nephrology.

Effects of angiotensin-receptor antagonists on erythrocytosis after renal transplantation.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis

C. Courivaud, D. Ducloux, Maria Yannaraki, 2021, Kidney International.

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2‐year follow‐up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002 .

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study

A. Heng, N. Kamar, A. Durrbach, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature

A. Heng, N. Kamar, T. Bachelet, 2017, PloS one.

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report.

C. Billerey, D. Ducloux, C. Bresson‐Vautrin, 1998, Transplantation.

G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation.

P. Tiberghien, E. Thervet, P. Saas, 2009, Transplantation.

Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1998, Clinical nephrology.

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2005, Kidney international.

Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study

L. Rostaing, C. Pouteil‐Noble, L. Frimat, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?

P. Saas, C. Courivaud, D. Ducloux, 2021, Frontiers in Medicine.

Chronic congestive heart failure associated with bilateral renal artery stenosis.

D. Ducloux, J. Chalopin, M. Jamali, 1997, Clinical nephrology.

Pre‐transplant end‐stage renal disease‐related immune risk profile in kidney transplant recipients predicts post‐transplant infections

P. Rieu, L. Frimat, P. Saas, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Losartan decreases hemoglobin in renal transplant recipients.

D. Ducloux, J. Chalopin, 1997, Transplantation proceedings.

Treatment of posttransplant erythrocytosis with losartan.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Transplantation proceedings.

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients.

F. Aubin, P. Carron, P. Humbert, 1998, Transplantation.

The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins.

P. Tiberghien, C. Ferrand, P. Saas, 2011, Human immunology.

Impact of pre‐transplant dialysis modality on post‐transplant diabetes mellitus after kidney transplantation

P. Rieu, O. Toupance, L. Frimat, 2011, Clinical transplantation.

LONG-TERM TOXICITY OF ANTITHYMOCYTE GLOBULIN INDUCTION MAY VARY WITH CHOICE OF AGENT: A SINGLE-CENTER RETROSPECTIVE STUDY

A. Kazory, B. Challier, D. Ducloux, 2004, Transplantation.

Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword.

P. Saas, C. Courivaud, D. Ducloux, 2017, Transplantation reviews.

ATG‐Induced Accelerated Immune Senescence: Clinical Implications in Renal Transplant Recipients

P. Rieu, P. Tiberghien, C. Ferrand, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Physiopathologie et traitement des complications du syndrome néphrotique

D. Ducloux, 2011 .

[Physiopathology and treatment of nephrotic syndrome complications].

D. Ducloux, 2011, Nephrologie & therapeutique.

Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins.

P. Rieu, A. Heng, L. Frimat, 2017, Transplant Immunology.

Pretransplant thymic function predicts acute rejection in antithymocyte globulin-treated renal transplant recipients.

P. Rieu, A. Heng, L. Frimat, 2016, Kidney international.

Hypertension in renal transplantation: donor and recipient risk factors.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2002, Clinical nephrology.

Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantation.

F. Aubin, M. Deschamps, P. Tiberghien, 2010, The Journal of investigative dermatology.

Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.

C. Billerey, D. Ducloux, J. Chalopin, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.

E. Deconinck, J. Cahn, D. Ducloux, 2005, Haematologica.

Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study

L. Doucet, J. Goujon, D. Nochy, 2020, Diagnostic Pathology.

Influence of Cyclooxygenase‐2 (COX‐2) Gene Promoter Polymorphism −765 on Graft Loss After Renal Transplantation

M. Deschamps, P. Tiberghien, C. Ferrand, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection *

P. Tiberghien, C. Ferrand, A. Duperrier, 2006, Transplant international : official journal of the European Society for Organ Transplantation.

Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis.

S. Semhoun-Ducloux, D. Ducloux, C. Bresson‐Vautrin, 1998, Transplantation.

Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study

F. Martinez, C. Lambert, J. Aniort, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

P. Tiberghien, P. Carron, D. Ducloux, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction : REFERENCE Study 3-Year Follow Up

L. Rostaing, C. Pouteil‐Noble, L. Frimat, 2014 .

Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects

K. Budde, P. Saas, S. Brakemeier, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cutaneous Alternaria infection in renal transplant recipients: a report of two cases with an unusual mode of transmission

R. Piarroux, G. Reboux, A. Kazory, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Cytomegalovirus and thromboembolism in renal transplantation.

A. Kazory, D. Ducloux, 2005, Transplantation.

Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases.

A. Kazory, A. Coaquette, D. Ducloux, 2004, Transplantation.

Early Corticosteroid Avoidance in Kidney Transplant Recipients Receiving ATG‐F Induction: 5‐Year Actual Results of a Prospective and Randomized Study

L. Rostaing, N. Kamar, J. Soulillou, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Gestational Choriocarcinoma Transmission Following Multiorgan Donation

J. Bergerat, L. Braun-Parvez, B. Moulin, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case‐controlled study

C. Rouzioux, C. Legendre, A. Ferroni, 1993, Journal of medical virology.

Renal transplantation and polyomavirus infection: recent clinical facts and controversies

A. Kazory, D. Ducloux, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants

P. Muret, Jennifer Lagoutte-Renosi, S. Davani, 2021, Journal of chemotherapy.

New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory Response

J. Pais de Barros, L. Lagrost, P. Saas, 2021, Frontiers in Immunology.

The case: a female with hyponatremia. Diagnosis: Postpartum panhypopituitarism (Sheehan syndrome).

A. Kazory, C. Courivaud, J. Bonneville, 2009, Kidney international.

T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies

P. Carron, E. Racadot, D. Ducloux, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation

P. Saas, C. Courivaud, D. Ducloux, 2020, Frontiers in Immunology.

One‐Year Post‐Transplant Weight Gain is a Risk Factor for Graft Loss

A. Kazory, D. Ducloux, J. Chalopin, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Trends in Tuberculosis Transmission

J. Miguet, S. Semhoun-Ducloux, D. Ducloux, 2000, Annals of Internal Medicine.

Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2010, Journal of the American Society of Nephrology : JASN.

Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti‐T‐lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction

L. Rostaing, N. Kamar, J. Soulillou, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Immune Monitoring of Kidney Recipients: Biomarkers to Appreciate Immunosuppression -Associated Complications

P. Saas, B. Gaugler, D. Ducloux, 2011 .

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up

L. Rostaing, C. Pouteil‐Noble, L. Frimat, 2010, Journal of transplantation.

Anti-class II antibodies in kidney transplant patients.

P. Tiberghien, P. Hervé, D. Ducloux, 2000, Transplantation proceedings.

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial

F. Jaisser, P. Rieu, P. Rossignol, 2018, Trials.

Impact of renal dysfunction on 1-year mortality after acute myocardial infarction.

F. Schiele, J. Bassand, R. Faivre, 2006, American heart journal.

Regulatory T cells and cancer: an undesired tolerance.

D. Ducloux, 2014, Kidney international.

Mycophenolate mofetil in cyclosporine-associated nephrotoxicity.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1998, Transplantation proceedings.

Posttransplant Immune Activation

P. Saas, C. Courivaud, D. Ducloux, 2017, Cell transplantation.

Thymic function, anti-thymocytes globulins, and cancer after renal transplantation.

P. Tiberghien, C. Borg, C. Ferrand, 2011, Transplant immunology.

CD4 lymphocytopenia in long-term renal transplant recipients.

P. Carron, E. Racadot, D. Ducloux, 1998, Transplantation proceedings.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges

J. Aniort, F. Maurier, A. Moktefi, 2022, Journal of the American Society of Nephrology : JASN.

A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion.

M. Mihatsch, E. Thervet, C. Legendre, 2000, Transplantation Proceedings.

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Cyclosporine withdrawal in stable renal transplant recipients after azathioprine‐mycophenolate mofetil conversion

M. Mihatsch, E. Thervet, A. Janin, 2000, Clinical transplantation.

End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation

P. Rieu, J. Pais de Barros, A. Heng, 2019, Front. Immunol..

Polycystic kidney size and outcomes on peritoneal dialysis: comparison with haemodialysis

É. Delabrousse, C. Courivaud, D. Ducloux, 2014, Clinical kidney journal.

Colchicine myopathy in renal transplant recipients on cyclosporin.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Is cytomegalovirus a cause of ureteral stricture in renal transplant recipients?

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1997, Transplant international : official journal of the European Society for Organ Transplantation.

Metabolic Syndrome and Atherosclerotic Events in Renal Transplant Recipients

A. Kazory, C. Courivaud, D. Ducloux, 2007, Transplantation.

Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients

C. Courivaud, D. Ducloux, J. Bamoulid, 2021, Clinical kidney journal.

Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients.

L. Rostaing, S. Quéré, N. Kamar, 2012, Clinical nephrology.

Impact of renal dysfunction and glucometabolic status on one month mortality after acute myocardial infarction

F. Schiele, F. Ecarnot, J. Bassand, 2007, Acute cardiac care.

Polyomaviruses and transplant patients: new concepts

A. Kazory, D. Ducloux, 2004, Transplant infectious disease : an official journal of the Transplantation Society.

Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial.

P. Rieu, E. Thervet, J. Souberbielle, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

T‐cell immune defect and B‐cell activation in renal transplant recipients with monoclonal gammopathies

P. Carron, E. Racadot, D. Ducloux, 1999 .

C-reactive protein and cardiovascular disease in peritoneal dialysis patients.

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2002, Kidney international.

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications

P. Saas, C. Courivaud, D. Ducloux, 2018, Immunity & ageing : I & A.

C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.

E. Daugas, E. Thervet, V. Frémeaux-Bacchi, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Posttransplant Diabetes Mellitus and Atherosclerotic Events in Renal Transplant Recipients: A Prospective Study

A. Kazory, D. Ducloux, J. Chalopin, 2005, Transplantation.

Predicting coronary heart disease in renal transplant recipients: a prospective study.

A. Kazory, D. Ducloux, J. Chalopin, 2004, Kidney international.

Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients.

E. Racadot, D. Ducloux, C. Bresson‐Vautrin, 1997, Transplantation.

IgA Vasculitis in Patients with Inflammatory Bowel Disease: new insights into the role of TNF-α blockers.

F. Maurier, B. Pigneur, F. Aubin, 2021, Rheumatology.

IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.

M. Deschamps, P. Tiberghien, C. Ferrand, 2006, Journal of the American Society of Nephrology : JASN.

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

E. Daugas, D. Chauveau, J. Boffa, 2019, Journal of clinical medicine.

Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples

M. Paindavoine, Sophie Félix, Laurent Martin, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach

C. Courivaud, D. Ducloux, 2022, Journal of personalized medicine.

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients

C. Courivaud, D. Ducloux, J. Bamoulid, 2022, Journal of Infection.

Use of pentoxifylline in membranous nephropathy

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 2001, The Lancet.

Organ Transplantation in Hereditary Fibrinogen A α-Chain Amyloidosis: A Case Series of French Patients.

G. Bobrie, J. Boffa, D. Nochy, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Late Persistent Positive EBV Viral Load and Risk of Solid Cancer in Kidney Transplant Patients

A. Coaquette, C. Courivaud, D. Ducloux, 2017, Transplantation.

Atheroembolic disease associated with the use of low-molecular-weight heparin during haemodialysis.

P. Carron, D. Ducloux, J. Chalopin, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography.

F. Schiele, F. Ecarnot, R. Chopard, 2018, The American journal of cardiology.

Venous Thromboembolism in Renal Transplant Recipients Cytomegalovirus and Thromboembolism in Renal Transplantation

A. Kazory, D. Ducloux, 2018 .

Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?

C. Courivaud, D. Ducloux, 2021, Kidney International.

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients

N. Kamar, C. Legendre, C. Courivaud, 2020, Kidney international reports.

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation

P. Saas, S. Brouard, M. Giral, 2023, Frontiers in immunology.

Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine.

G. Mantion, J. Miguet, S. Semhoun-Ducloux, 2000, Transplantation proceedings.

REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme

C. Courivaud, D. Ducloux, 2022, Kidney International.

Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients

J. Dumortier, A. Heng, N. Kamar, 2021, Kidney International Reports.

Homocysteine in renal disease.

D. Ducloux, J. Chalopin, G. Motte, 2000, Clinical Laboratory.

Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.

F. Berthoux, L. Rostaing, N. Kamar, 2006, Transplantation proceedings.

Successful management of respiratory failure can improve renal function.

A. Kazory, D. Ducloux, 2009, American Journal of Critical Care.

[A rare cause of anemia in a chronic dialyzed patient].

D. Ducloux, J. Bamoulid, T. Crépin, 2012, Nephrologie & therapeutique.

Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?

R. Gibey, D. Ducloux, J. Chalopin, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients.

G. Toubin, Aboubakr Abdelfatah, Didier Ducloux, 2002, Transplantation.

Triglyceride-Glucose Index and cardiovascular events in kidney transplant recipients

C. Courivaud, D. Ducloux, J. Bamoulid, 2023, Kidney International Reports.

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status

C. Courivaud, D. Ducloux, Maria Yannaraki, 2021, Clinical kidney journal.

Ocular Venous Occlusion and Hyperhomocysteinemia

D. Ducloux, C. Bresson‐Vautrin, J. Chalopin, 1999, Annals of Internal Medicine.

Potential influence of dialysis modality on post-transplantation diabetes mellitus risk.

C. Courivaud, D. Ducloux, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant Transfusion

D. Vernerey, P. Saas, C. Courivaud, 2023, JAMA network open.

[Premature immune senescence and chronic kidney disease: Update and perspectives].

P. Saas, C. Courivaud, D. Ducloux, 2019, Nephrologie & therapeutique.

Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.

R. Gibey, D. Ducloux, C. Bresson‐Vautrin, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

levels due to concurrent metronidazole therapy

Besançon, D. Ducloux, M. Jamali, 2017 .